Description: WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
17011 Beach Boulevard
Huntington Beach,
CA
92647
United States
Phone:
714-848-3200
Officers
| Name | Title |
|---|---|
| Mr. Steven Fox | Chief Executive Officer |
| Mr. Phill Richer | Director of Sales and Marketing |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Financials |
|---|---|
| GIC Group: | Financial Services |
| GIC Industry: | Capital Markets |
| GIC Sub-Industry: | Asset Management & Custody Banks |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.0553 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |